Skip to main content

Table 1 Patient characteristics

From: Premedication with intranasal dexmedetomidine decreases barbiturate requirement in pediatric patients sedated for magnetic resonance imaging: a retrospective study

  Group Dexmedetomidine (DEX) Thiopental (THIO) p-value
  n mean (SD)a n mean (SD)a
Age (yr) ALL 100 4.50 (2.56) 100 4.06 (2.39) 0.22
  0–2 years 20 1.21 (0.56) 24 1.24 (0.45)  
  2–6 years 50 3.93 (1.16) 53 3.85 (1.09)  
  6–11 years 30 7.64 (1.30) 23 7.47 (1.31)  
Weight (kg) ALL 100 18.8 (7.5) 100 17.4 (6.4) 0.19
  0–2 years 20 10.3 (1.9) 24 10.5 (2.1)  
  2–6 years 50 17.4 (3.3) 53 17.0 (3.4)  
  6–11 years 30 26.8 (7.1) 23 25.6 (5.7)  
BMI (kg/m2) ALL 100 16.5 (2.2) 100 16.5 (1.8) 0.68
  0–2 years 20 17.4 (2.1) 24 17.3 (2.2)  
  2–6 years 50 16.3 (2.0) 53 16.5 (1.6)  
  6–11 years 30 16.3 (2.4) 23 15.9 (1.7)  
Duration of MRI (min) ALL 100 43 (41–57) 100 47 (35–50) 0.001
  0–2 years 20 43 (36–57) 24 49 (43–60) 0.124
  2–6 years 50 42 (35–48) 53 46 (40–57) 0.002
  6–11 years 30 43 (34–55) 23 50 (37–55) 0.804
  1. aMean and SD reported, except for duration of MRI, for which median and IQR are shown